CEOInterviews.AI
Start App
Try: AI strategy tariffs earnings guidance layoffs interest rates growth

Yaky Yanay

CEO, Pluri

Search every verified Yaky Yanay interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Yaky Yanay, CEO of Pluri, has described the company’s proprietary 3D cell expansion platform as one of the most advanced systems globally, protected by approximately 250 patents. He stated that Pluri operates across two core verticals: one focused on longevity, therapeutics, and aesthetics using placenta-derived cells, and another in food technology where the same platform is used to create ingredients such as cultivated meat, coffee, and cacao. Yanay said the company’s strategy involves partnering with leading firms — including a subsidiary of a major Chinese food company, the largest food company in Israel, Buhler, and IKEA — to bring products to market<｜begin▁of▁file｜>. He noted that initial transactions were in the range of $100,000 and that he expects them to expand to the level of millions, with the goal of making revenue the key driver for the company. Yanay has also highlighted Pluri’s work in developing a cell therapy for acute radiation syndrome in collaboration with the U.S. National Institutes of Health and Department of Defense, stating that the product was able to increase survival from about 30% to close to 100% in studies. He said the company received a $4 million contract from the NIH to continue development and that his goal is to have the product stockpiled in the U.S. In addition, Yanay discussed a new platform for placenta-based immunotherapy targeting solid tumors, which he said is in the discovery phase and moving toward an IND application. He also mentioned that Pluri launched a new company focused on cell-based coffee, citing projections that 50% of global coffee production could be lost in the next 20 years due to climate change.

Recent appearances

Notable quotes

“I'm going to take 50% off my salary and you like the VPs need to take 30% off and the lower management will do 25% off and while we going to protect the employees that are making relatively less amount of money.”

“We developed a unique cell type with the U.S. military and the National Institutes of Health, and when used in populations exposed to very high levels of nuclear radiation we were able to increase survival from about 30% to close to 100%.”

“The U.S. is spending almost 20% of its GDP on healthcare and that keeps rising — it's insane and not sustainable. Either we face financial bankruptcy or a moral bankruptcy where we can't treat our elders, or we must find new solutions focused on prevention and regeneration.”

“They told me 'in 20 years we're going to lose 50% of the global production because of climate change and need to find the solution.'”

“On cultivated meat we see different opinions: on one hand we're seeing Florida trying to avoid it and trying to pass a bill against it, but in other places they're trying to adopt it, especially in the Asian market.”

“We need to transform life science from hospitalization and chronic treatment to regeneration and recovery. We need to shift this system from being a sicker system to a healthcare system.”

The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →